{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T06:28:05Z","timestamp":1770272885435,"version":"3.49.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,4]]},"DOI":"10.7759\/cureus.102967","type":"journal-article","created":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T16:26:33Z","timestamp":1770222393000},"source":"Crossref","is-referenced-by-count":0,"title":["ROS-1 Positive Pleural Adenocarcinoma Diagnosed by Semirigid Thoracoscope Using Cryo-Probe in a Middle-Aged Lady: A Case Report"],"prefix":"10.7759","author":[{"given":"Jyoti","family":"Bajpai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shubhajeet","family":"Roy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Surya","family":"Kant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.2478\/raon-2013-0068","article-title":"Semirigid thoracoscopy: an effective method for diagnosing pleural malignancies","volume":"48","author":"Rozman A","year":"2014","unstructured":"Rozman A, Camlek L, Kern I, Malovrh MM. Semirigid thoracoscopy: an effective method for diagnosing pleural malignancies. Radiol Oncol. 2014, 48:67-71. 10.2478\/raon-2013-0068","journal-title":"Radiol Oncol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1159\/000497212","article-title":"Pleural cryobiopsy versus flexible forceps biopsy in subjects with undiagnosed exudative pleural effusions undergoing semirigid thoracoscopy: a crossover randomized trial (COFFEE trial)","volume":"98","author":"Dhooria S","year":"2019","unstructured":"Dhooria S, Bal A, Sehgal IS, Prasad KT, Muthu V, Aggarwal AN, Agarwal R. Pleural cryobiopsy versus flexible forceps biopsy in subjects with undiagnosed exudative pleural effusions undergoing semirigid thoracoscopy: a crossover randomized trial (COFFEE trial). Respiration. 2019, 98:133-141. 10.1159\/000497212","journal-title":"Respiration"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa011954","article-title":"Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer","volume":"346","author":"Schiller JH","year":"2002","unstructured":"Schiller JH, Harrington D, Belani CP, et al.. Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer. N Engl J Med. 2002, 346:92-98. 10.1056\/NEJMoa011954","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.15.0375","article-title":"Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer","volume":"26","author":"Scagliotti GV","year":"2008","unstructured":"Scagliotti GV, Parikh P, von Pawel J, et al.. Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer. J Clin Oncol. 2008, 26:3543-3551. 10.1200\/JCO.2007.15.0375","journal-title":"J Clin Oncol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1159\/000444089","article-title":"Safety and diagnostic yield of transbronchial lung cryobiopsy in diffuse parenchymal lung diseases: a comparative study versus video-assisted thoracoscopic lung biopsy and a systematic review of the literature","volume":"91","author":"Ravaglia C","year":"2016","unstructured":"Ravaglia C, Bonifazi M, Wells AU, et al.. Safety and diagnostic yield of transbronchial lung cryobiopsy in diffuse parenchymal lung diseases: a comparative study versus video-assisted thoracoscopic lung biopsy and a systematic review of the literature. Respiration. 2016, 91:215-227. 10.1159\/000444089","journal-title":"Respiration"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray F","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024, 74:229-263. 10.3322\/caac.21834","journal-title":"CA Cancer J Clin"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2019.01.009","article-title":"Molecular analysis of plasma from patients with ROS1-positive NSCLC","volume":"14","author":"Dagogo-Jack I","year":"2019","unstructured":"Dagogo-Jack I, Rooney M, Nagy RJ, et al.. Molecular analysis of plasma from patients with ROS1-positive NSCLC. J Thorac Oncol. 2019, 14:816-824. 10.1016\/j.jtho.2019.01.009","journal-title":"J Thorac Oncol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2008.07.006","article-title":"The multifaceted roles of the receptor tyrosine kinase ROS in development and cancer","volume":"1795","author":"Acquaviva J","year":"2009","unstructured":"Acquaviva J, Wong R, Charest A. The multifaceted roles of the receptor tyrosine kinase ROS in development and cancer. Biochim Biophys Acta. 2009, 1795:37-52. 10.1016\/j.bbcan.2008.07.006","journal-title":"Biochim Biophys Acta"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(13)70604-1","article-title":"Afatinib versus cisplatin plus gemcitabine for first-line treatment of Asian patients with advanced non-small-cell lung cancer harbouring EGFR mutations (LUX-Lung 6): an open-label, randomised phase 3 trial","volume":"15","author":"Wu YL","year":"2014","unstructured":"Wu YL, Zhou C, Hu CP, et al.. Afatinib versus cisplatin plus gemcitabine for first-line treatment of Asian patients with advanced non-small-cell lung cancer harbouring EGFR mutations (LUX-Lung 6): an open-label, randomised phase 3 trial. Lancet Oncol. 2014, 15:213-222. 10.1016\/S1470-2045(13)70604-1","journal-title":"Lancet Oncol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1406766","article-title":"Crizotinib in ROS1-rearranged non-small-cell lung cancer","volume":"371","author":"Shaw AT","year":"2014","unstructured":"Shaw AT, Ou SH, Bang YJ, et al.. Crizotinib in ROS1-rearranged non-small-cell lung cancer. N Engl J Med. 2014, 371:1963-1971. 10.1056\/NEJMoa1406766","journal-title":"N Engl J Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1378\/chest.111.4.970","article-title":"Diagnostic value of tests that discriminate between exudative and transudative pleural effusions","volume":"111","author":"Heffner JE","year":"1997","unstructured":"Heffner JE, Brown LK, Barbieri CA. Diagnostic value of tests that discriminate between exudative and transudative pleural effusions. Chest. 1997, 111:970-980. 10.1378\/chest.111.4.970","journal-title":"Chest"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1159\/000112221","article-title":"Diagnostic work-up of pleural effusions","volume":"75","author":"Froudarakis ME","year":"2008","unstructured":"Froudarakis ME. Diagnostic work-up of pleural effusions. Respiration. 2008, 75:4-13. 10.1159\/000112221","journal-title":"Respiration"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmcr.2023.101840","article-title":"Examination of the utility of cryobiopsy for tuberculous pleurisy in thoracoscopy: a report of seven cases","volume":"43","author":"Ishii S","year":"2023","unstructured":"Ishii S, Ishida A, Sugiura Y, Takasaki J, Izumi S, Hojo M. Examination of the utility of cryobiopsy for tuberculous pleurisy in thoracoscopy: a report of seven cases. Respir Med Case Rep. 2023, 43:101840. 10.1016\/j.rmcr.2023.101840","journal-title":"Respir Med Case Rep"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00033011","article-title":"Cryobiopsy increases the diagnostic yield of endobronchial biopsy: a multicentre trial","volume":"39","author":"Hetzel J","year":"2012","unstructured":"Hetzel J, Eberhardt R, Herth FJ, et al.. Cryobiopsy increases the diagnostic yield of endobronchial biopsy: a multicentre trial. Eur Respir J. 2012, 39:685-690. 10.1183\/09031936.00033011","journal-title":"Eur Respir J"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13081794","article-title":"Circulating biomarkers of response and toxicity of immunotherapy in advanced non-small cell lung cancer (NSCLC): a comprehensive review","volume":"13","author":"Indini A","year":"2021","unstructured":"Indini A, Rijavec E, Grossi F. Circulating biomarkers of response and toxicity of immunotherapy in advanced non-small cell lung cancer (NSCLC): a comprehensive review. Cancers (Basel). 2021, 13:1794. 10.3390\/cancers13081794","journal-title":"Cancers (Basel)"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12113293","article-title":"Focus on ROS1-positive non-small cell lung cancer (NSCLC): crizotinib, resistance mechanisms and the newer generation of targeted therapies","volume":"12","author":"D'Angelo A","year":"2020","unstructured":"D'Angelo A, Sobhani N, Chapman R, et al.. Focus on ROS1-positive non-small cell lung cancer (NSCLC): crizotinib, resistance mechanisms and the newer generation of targeted therapies. Cancers (Basel). 2020, 12:3293. 10.3390\/cancers12113293","journal-title":"Cancers (Basel)"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-18-0484","article-title":"Repotrectinib (TPX-0005) is a next-generation ROS1\/TRK\/ALK inhibitor that potently inhibits ROS1\/TRK\/ALK solvent- front mutations","volume":"8","author":"Drilon A","year":"2018","unstructured":"Drilon A, Ou SI, Cho BC, et al.. Repotrectinib (TPX-0005) is a next-generation ROS1\/TRK\/ALK inhibitor that potently inhibits ROS1\/TRK\/ALK solvent- front mutations. Cancer Discov. 2018, 8:1227-1236. 10.1158\/2159-8290.CD-18-0484","journal-title":"Cancer Discov"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2017.04.022","article-title":"ROS1 protein-tyrosine kinase inhibitors in the treatment of ROS1 fusion protein-driven non-small cell lung cancers","volume":"121","author":"Roskoski R Jr","year":"2017","unstructured":"Roskoski R Jr. ROS1 protein-tyrosine kinase inhibitors in the treatment of ROS1 fusion protein-driven non-small cell lung cancers. Pharmacol Res. 2017, 121:202-212. 10.1016\/j.phrs.2017.04.022","journal-title":"Pharmacol Res"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.cllc.2019.06.007","article-title":"ROS1-rearranged NSCLC with secondary resistance mutation: case report and current perspectives","volume":"20","author":"Guisier F","year":"2019","unstructured":"Guisier F, Piton N, Salaun M, Thiberville L. ROS1-rearranged NSCLC with secondary resistance mutation: case report and current perspectives. Clin Lung Cancer. 2019, 20:e593-e596. 10.1016\/j.cllc.2019.06.007","journal-title":"Clin Lung Cancer"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/450249-ros-1-positive-pleural-adenocarcinoma-diagnosed-by-semirigid-thoracoscope-using-cryo-probe-in-a-middle-aged-lady-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T16:26:33Z","timestamp":1770222393000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/450249-ros-1-positive-pleural-adenocarcinoma-diagnosed-by-semirigid-thoracoscope-using-cryo-probe-in-a-middle-aged-lady-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,4]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.102967","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2,4]]}}}